Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(3S,6S,9S,12S)-1-((S)-1-((3S,6S,9S,15S,21S)-1-((3R,8R,14S,20S,23S,28aS)-8-amino-20-(4-aminobutyl)-23-isopropyl-14-methyl-1,9,12,15,18,21,24-heptaoxohexacosahydropyrrolo[2,1-g][1,2,5,8,11,14,17,20,23]dithiaheptaazacyclohexacosin-3-yl)-6-benzyl-15-sec-butyl-3-(4-hydroxybenzyl)-21-((R)-1-hydroxyethyl)-9-isopropyl-1,4,7,10,13,16,19-heptaoxo-2,5,8,11,14,17,20-heptaazadocosane)pyrrolidin-2-yl)-9-benzyl-3-sec-butyl-12-(2-carboxyethyl)-6-(hydroxymethyl)-1,4,7,10,13-pentaoxo-2,5,8,11,14-pentaazahexadecan-16-oic acid
ID: ALA1945677
PubChem CID: 57390880
Max Phase: Preclinical
Molecular Formula: C96H142N22O27S2
Molecular Weight: 2100.45
Molecule Type: Protein
Associated Items: